[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lipsky et al., 1977 - Google Patents

Inhibition of antigen-and mitogen-induced human lymphocyte proliferation by gold compounds.

Lipsky et al., 1977

View PDF
Document ID
13148033081587272625
Author
Lipsky P
Ziff M
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

Gold sodium thiomalate (GST) inhibited in vitro antigen-and mitogen-triggered human lymphocyte DNA synthesis. Inhibition of responsiveness was observed with concentrations of GST equivalent to gold levels found in serum or tissues of patients receiving …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Similar Documents

Publication Publication Date Title
Lipsky et al. Inhibition of antigen-and mitogen-induced human lymphocyte proliferation by gold compounds.
Goodwin et al. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.
Goodwin et al. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro: changes with mitogen dose and preincubation
Richman et al. Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes.
Lederman et al. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation
Lipsky et al. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts
Metz et al. Deranged DNA synthesis by bone marrow from vitamin B12‐deficient humans
Atkinson et al. Stimulation by alcohols of cyclic AMP metabolism in human leukocytes: Possible role of cyclic AMP in the anti-inflammatory effects of ethanol
Gallin et al. The regulatory role of divalent cations in human granulocyte chemotaxis: Evidence for an association between calcium exchanges and microtubule assembly
Allen et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency
Freedman Early biochemical events in lymphocyte activation: I. Investigations on the nature and significance of early calcium fluxes observed in mitogen-induced T and B lymphocytes
Green et al. Studies on the Mechanism of Lymphocyte-Mediated Cytolysis: XI. The Role of Lectin in Lectin-Dependent Cell-Mediated Cytotoxicity
Rosenau et al. Early biochemical alterations induced by lymphotoxin in target cells
Bass et al. Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes
Blomgren Steroid sensitivity of the response of human lymphocytes to phytohemagglutinin and pokeweed mitogen: role of phagocytic cells
Kanazawa et al. Noncobalamin vitamin B12 analogues in human red cells, liver, and brain
Jensen et al. Depletion of NK by cellular immunoadsorption
Taniguchi et al. Mitogenic responsiveness and monocyte-lymphocyte interaction of early and late rosette-forming cell populations of human peripheral blood lymphocytes
Baldessarini et al. Adenosylmethionine elevation in leukemic white blood cells
Harris et al. Increased cytolytic T lymphocyte activity induced by 2-mercaptoethanol in mixed leukocyte cultures: kinetics and possible mechanisms of action
Badger et al. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug
Boillot et al. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro
Magnuson et al. In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.
Alonso et al. Modulatory role of cyclic AMP in the release of platelet-activating factor from human polymorphonuclear leucocytes.
McGarrity et al. Inhibition of neutrophil functions by platelets and platelet-derived products: description of multiple inhibitory properties